ライフサイエンスコーパス: equilibrative

1 TM4 mutants were not sensitive to equilibrative (12 mM) sodium concentrations, thereby rul

2 curs primarily via broad-specificity, es (e, equilibrative; 5, sensitive to NBMPR inhibition) transpo

3 Several transport activities, including equilibrative and concentrative mechanisms, have been id

4 Equilibrative cation-chloride cotransporters (CCCs) move

5 suggested that this acceleration may involve equilibrative (ENT) and concentrative (CNT) nucleoside t

6 Simulating equilibrative glucose inflow via the narrow external ori

7 The class 1 equilibrative glucose transporters GLUT1 and GLUT4 are s

8 Activity assessments at equilibrative [Na(+)] revealed numerous Na(+)-sensitive

9 kly inhibited by the classical inhibitors of equilibrative nucleoside transport, dipyridamole, dilaze

10 rter (CNT) blocker phloridzin but not by the equilibrative nucleoside transporter (ENT) blocker dipyr

11 while requiring intracellular uptake via the equilibrative nucleoside transporter (ENT) ENT1 or the c

12 s a newly cloned transporter assigned to the equilibrative nucleoside transporter (ENT) family (SLC29

13 Transporters of the equilibrative nucleoside transporter (ENT) family promot

14 de Transporter 1 (PfENT1) is a member of the equilibrative nucleoside transporter (ENT) gene family.

15 anol-sensitive adenosine transporter, type 1 equilibrative nucleoside transporter (ENT1), drink more

16 the nitrobenzylthioinosine (NBMPR)-sensitive equilibrative nucleoside transporter (ENT1), incubation

17 adenosine signaling by inhibiting the type 1 equilibrative nucleoside transporter (ENT1), whereas chr

18 ng to a novel isoform of the NBMPR-sensitive equilibrative nucleoside transporter (ENT1).

19 or DNA and correlating its uptake with human equilibrative nucleoside transporter (hENT1) levels, str

20 The human equilibrative nucleoside transporter (hENT1) protein tra

21 s thymidine kinase gene (hsv-tk) and a human equilibrative nucleoside transporter (hENT1).

22 The rat equilibrative nucleoside transporter (rENT1) was reveale

23 Erythrocyte equilibrative nucleoside transporter 1 (eENT1) levels ar

24 They import purines via equilibrative nucleoside transporter 1 (ENT1) homologs.

25 s a consequence of ticagrelor inhibiting the equilibrative nucleoside transporter 1 (ENT1) on platele

26 Overexpression of equilibrative nucleoside transporter 1 (ENT1) or concent

27 ecently, a variant of adenosine transporter, equilibrative nucleoside transporter 1 (ENT1), was assoc

28 s RBV uptake by preventing the expression of equilibrative nucleoside transporter 1 (ENT1).

29 iation in the last extracellular loop of the equilibrative nucleoside transporter 1 (ENT1; also calle

30 Inhibitor and substrate interactions with equilibrative nucleoside transporter 1 (ENT1; SLC29A1) a

31 We identified the human equilibrative nucleoside transporter 1 (hENT1) as the mo

32 The human equilibrative nucleoside transporter 1 (hENT1) is an imp

33 We have previously shown that the human equilibrative nucleoside transporter 1 (hENT1) is expres

34 e whether the nucleoside transporters, human equilibrative nucleoside transporter 1 (hENT1) or human

35 nomolar concentrations specifically to human equilibrative nucleoside transporter 1 (hENT1) produced

36 H-Thymidine transport was dominated by human equilibrative nucleoside transporter 1 (hENT1) under bot

37 toxicity include the activities of the human equilibrative nucleoside transporter 1 (hENT1), deoxycyt

38 The expression of human equilibrative nucleoside transporter 1 (hENT1), thymidin

39 cells expressing thymidine kinase and human equilibrative nucleoside transporter 1 (hENT1).

40 The Plasmodium falciparum Equilibrative Nucleoside Transporter 1 (PfENT1) is a mem

41 CBD inhibited adenosine uptake via equilibrative nucleoside transporter 1 and synergistical

42 inding studies confirm that CBD binds to the equilibrative nucleoside transporter 1 with a Ki < 250 n

43 enzymes (connexin43, connexin37, pannexin-1, equilibrative nucleoside transporter 1, CD39, CD73, ecto

44 (3)H-FMAU transport was dominated by human equilibrative nucleoside transporter 2.

45 Here, we found that mice lacking the equilibrative nucleoside transporter 3 (ENT3) developed

46 mercaptopurine riboside (NBMPR)-insensitive, equilibrative nucleoside transporter ei by functional co

47 o the recently cloned human NBMPR-sensitive, equilibrative nucleoside transporter ENT1 and thus was d

48 ble to penetrate into cells deficient in the equilibrative nucleoside transporter ENT2, and reconstit

49 identifies three transport mechanisms of the equilibrative nucleoside transporter family by which nuc

50 the first demonstration that members of the equilibrative nucleoside transporter family can be elect

51 Permeases of the equilibrative nucleoside transporter family mediate the

52 Previous studies have implicated the equilibrative nucleoside transporter family member equil

53 Permeases belonging to the equilibrative nucleoside transporter family promote upta

54 The first mammalian examples of the equilibrative nucleoside transporter family to be charac

55 LdNT2 is a member of the equilibrative nucleoside transporter family, which posse

56 ituted gate operates in other members of the equilibrative nucleoside transporter family.

57 PfNT2 is, like PfNT1, a member of the equilibrative nucleoside transporter family.

58 but exhibits low homology to members of the equilibrative nucleoside transporter family.

59 s that is homologous to other members of the equilibrative nucleoside transporter family.

60 substantial homology to other members of the equilibrative nucleoside transporter family.

61 topology similar to members of the mammalian equilibrative nucleoside transporter family.

62 ishmania donovani express two members of the equilibrative nucleoside transporter family; LdNT1 encod

63 exposure of SKOV-3 cells to dipyridamole, an equilibrative nucleoside transporter inhibitor; APCP, a

64 ENT1 is an equilibrative nucleoside transporter that enables trans-

65 onstrate that Fun26, a homolog of human ENT (equilibrative nucleoside transporter), localizes to the

66 on of the adenosine transporter ENT1 (type 1 equilibrative nucleoside transporter), which provides pr

67 The human equilibrative nucleoside transporter, hENT1, which is se

68 hich inhibits transport of adenosine through equilibrative nucleoside transporter, raised the measure

69 brative nucleoside transporter family member equilibrative nucleoside transporter-1 (ENT1) in the reg

70 lism by potently and directly inhibiting the equilibrative nucleoside transporter-1 (ENT1).

71 Low expression of human equilibrative nucleoside transporter-1 (hENT1) may resul

72 raC-8C cells that are deficient in the human equilibrative nucleoside transporter-1, the IC(50) of Ge

73 press both a nucleoside kinase as well as an equilibrative nucleoside transporter.

74 recently cloned dipyridamole-sensitive human equilibrative nucleoside transporter.

75 enosine kinase, adenosine deaminase, and the equilibrative nucleoside transporter: mature receptors w

76 entrative nucleoside transporters (CNTs) and equilibrative nucleoside transporters (ENTs) are importa

77 Equilibrative nucleoside transporters (ENTs) are polytop

78 Consistent with the notion that equilibrative nucleoside transporters (ENTs) terminate a

79 Equilibrative nucleoside transporters (ENTs) translocate

80 ards the intracellular compartment by way of equilibrative nucleoside transporters (ENTs), we hypothe

81 ignaling is terminated by its uptake through equilibrative nucleoside transporters (ENTs).

82 e occurred by translocation of adenosine via equilibrative nucleoside transporters (ENTs).

83 the hypothesis that human concentrative and equilibrative nucleoside transporters (hCNT1 and hENT1)

84 ntine) is a clinically used vasodilator with equilibrative nucleoside transporters 1 and 2 (ENT1 and

85 We stably transfected the cloned human equilibrative nucleoside transporters 1 and 2 (hENT1 and

86 ntracellular uptake depends predominantly on equilibrative nucleoside transporters after conversion o

87 Equilibrative nucleoside transporters are a unique famil

88 studies demonstrate that the NBMPR-sensitive equilibrative nucleoside transporters are novel and unex

89 sine A2B receptor agonists and inhibition of equilibrative nucleoside transporters by dipyridamole ma

90 Equilibrative nucleoside transporters encompass two cons

91 1 receptors but required adenosine uptake by equilibrative nucleoside transporters followed by its (i

92 Equilibrative nucleoside transporters of the SLC29 famil

93 Equilibrative nucleoside transporters play essential rol

94 permease is related in sequence to mammalian equilibrative nucleoside transporters.

95 osine reuptake into proximal tubule cells by equilibrative nucleotide transporter 1, which can be inh

96 translocated rapidly into the cells by both equilibrative-sensitive and -insensitive nucleoside tran

97 GLUT1-catalyzed equilibrative sugar transport across the mammalian blood

98 Blocking equilibrative transport using the inhibitor nitrobenzylm

99 s within TMD 3-6, which are conserved across equilibrative transporter sequences from several species